Chemo mouth is a common side effect of undergoing chemotherapy. Dr. Rajiv Saini discusses the symptoms, risks and best ...
Regular dental checkups are essential to maintain good oral health; they aid in detecting any dental issues early on, thereby preventing serious problems.
It’s a $4 billion a year industry that includes fraudulent anti-cancer drugs and opioid medications. Here is what patients need to know about the risk of counterfeit drugs.
APL was once a highly fatal disease, with up to 30% of patients dying early from complications. Traditional treatments often ...
Based on work Dr. Petrylak presented at ASCO 2024 looking at dose adjustment and efficacy of enfortumab vedotin, most ...
ASCO GU 2025: High-Dose Chemotherapy in Testicular Cancer: Current Evidence and Clinical Indications
Both Indiana University and Memorial Sloan Kettering Cancer Center (MSKCC) have published their series’ of salvage high-dose ...
Researchers report that the type of tissue samples used is crucial when assessing a person’s biological age, which reflects ...
Systemic circulation of chemotherapy drugs leads to off-target side effects, premature drug loss, and limited therapeutic ...
Paolo Tarantino, MD, PhD, discusses elacestrant as a treatment option for patients with ESR1-mutated metastatic breast cancer in the second line.
OPTYX study shows many patients with advanced prostate cancer preferred oral relugolix over injectables for androgen deprivation therapy.
When Melissa Ames started having tooth pain, she went to the dentist. However, it wasn’t just a toothache from a cavity that ...
Olema Pharmaceuticals is developing palazestrant, an oral SERD in phase 3 trials for ER+/HER2- metastatic breast cancer. Read why OLMA stock is a Hold.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results